J. Toyota

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis C

Norio Hayashi, Takeshi Okanoue, Hirohito Tsubouchi et al. · Journal of Viral Hepatitis · 2011 · 118 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan

Shunsuke Ohnishi, Jong-Hon Kang, Hitoe Maekubo et al. · Hepatology Research · 2006 · 63 citations

Medicine, Genetics, Infectious Diseases +15

The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

S Iino, J. Toyota, H. Kumada et al. · Journal of Viral Hepatitis · 2005 · 57 citations

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +15

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

Yoshiyasu Karino, Itaru Ozeki, Shuhei Hige et al. · Journal of Viral Hepatitis · 2013 · 41 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Infrequent widespread microsatellite instability in hepatocellular carcinomas.

Hiroyuki Yamamoto, Fumio Itoh, Hiroshi Fukushima et al. · International Journal of Oncology · 2000 · 40 citations

Medicine, Genetics, Oncology +17